Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Schistosoma tegument is a complex, syncytial cytoplasmic layer that forms the outer surface of the adult blood fluke, serving as the vital interface between the parasite and its human host (Skelly & Wilson, 2006). It performs multiple essential biological functions, including the absorption of nutrients such as glucose and amino acids, the regulation of osmotic balance, and the execution of sophisticated immune evasion strategies like molecular mimicry and rapid membrane turnover (Braschi et al., 2006). Structurally, it is unique for its double-lipid bilayer, or heptalaminar membrane, which protects the worm from the host's proteolytic enzymes and immune effectors. The tegument is the primary site of action for praziquantel, the standard treatment for schistosomiasis, which causes immediate tegumental damage and exposes the parasite to host immune attack (Doenhoff et al., 2008). Because it is directly exposed to the host's blood and contains numerous essential proteins, the tegument is a high-priority target for the development of new drugs and vaccines aimed at controlling schistosomiasis (CDC, 2022).
Anthelmintic drugs like praziquantel disrupt the tegumental integrity by inducing a rapid influx of calcium ions, which leads to severe vacuolization, surface blebbing, and muscle contraction (Doenhoff et al., 2008). This damage exposes sequestered parasite antigens to the host's immune system, facilitating the recruitment of leucocytes and subsequent parasite clearance (Skelly & Wilson, 2006).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Schistosoma tegument.